By continuing to use the site you agree to our Privacy & Cookies policy

NICE retracts diabetic macular oedema drug refusal

Thousands of people with a devastating eye condition could be offered a potentially sight-saving treatment following a U-turn by the National Institute for Health and Clinical Excellence.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units